Sanofi-Aventis U.S. LLC drugs

14 results

Admelog (insulin lispro)

(insulin lispro)
Sanofi-Aventis U.S. LLC
Usage: ADMELOG is indicated for improving glycemic control in adults and pediatric patients with diabetes mellitus.

Apidra (insulin glulisine)

(insulin glulisine)
sanofi-aventis U.S. LLC
Usage: APIDRA is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.
Sanofi-Aventis U.S. LLC
Usage: AVAPRO® is indicated for treating hypertension, reducing blood pressure to lower cardiovascular event risks, and for managing diabetic nephropathy in type 2 diabetes patients with hypertension and proteinuria. It may be used alone or with other antihypertensive agents to achieve blood pressure goals and protect kidney function.
sanofi-aventis U.S. LLC
Usage: DUPIXENT is indicated for the treatment of moderate-to-severe atopic dermatitis, asthma (eosinophilic phenotype), chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, chronic obstructive pulmonary disease (eosinophilic phenotype), and chronic spontaneous urticaria in patients meeting specific criteria.
Sanofi-Aventis U.S. LLC
Usage: Elitek is indicated for managing elevated plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumors undergoing anticancer therapy that may cause tumor lysis. It is approved for a single course of treatment.
Sanofi-Aventis U.S. LLC
Usage: Fexinidazole Tablets are indicated for treating both first-stage and second-stage human African trypanosomiasis (HAT) caused by *Trypanosoma brucei gambiense* in patients aged 6 years and older, weighing at least 20 kg. Limited use is advised in severe second-stage HAT cases with high CSF-WBC counts.
Sanofi-Aventis U.S. LLC
Usage: JEVTANA® is indicated for use with prednisone in treating metastatic castration-resistant prostate cancer in patients who have previously undergone treatment with a docetaxel-containing regimen.
sanofi-aventis U.S. LLC
Usage: KEVZARA® is indicated for adults with moderately to severely active rheumatoid arthritis (inadequate response to DMARDs), polymyalgia rheumatica (inadequate response or intolerance to corticosteroids), and for treating active polyarticular juvenile idiopathic arthritis in patients weighing 63 kg or more.

Lantus (insulin glargine)

(insulin glargine)
sanofi-aventis U.S. LLC
Usage: LANTUS is indicated for improving glycemic control in adults and pediatric patients with diabetes mellitus. It is not recommended for treating diabetic ketoacidosis.

Merilog (insulin aspart-szjj)

(insulin aspart-szjj)
Sanofi-Aventis U.S. LLC
Usage: Merilog is indicated for improving glycemic control in both adults and pediatric patients with diabetes mellitus.